Medicine guide
Elzonris 1mg / ml
As listed in the register: Elzonris 1mg / ml, Konzentrat zur Herstellung einer Infusionslösung
1mg / ml ·
- Prescription only
- Cancer treatments and immune-system medicines
- Active substance
- Tagraxofuspum
- Made by
- Stemline Therapeutics Switzerland GmbH
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Blastische plasmazytoide dendritische Zellneoplasie (BPDCN)
From the official label · 2026-09-30 · Swissmedic
Details
| Made by | Stemline Therapeutics Switzerland GmbH |
|---|---|
| Active substance | Tagraxofuspum |
| Used in | Cancer treatments and immune-system medicines |
| Strength | 1mg / ml |
| Classification | L01XX67 · Cancer treatments and immune-system medicines |
| Dispensing (as stated by the register) | Abgabekategorie A |
| Name in the register | Elzonris 1mg / ml, Konzentrat zur Herstellung einer Infusionslösung |
| Packs | 1 Durchstechflasche(n) |
| Zulassungsnummer | 68797 |
| Dosisstärke | 1 |
Source: Zugelassene Packungen Humanarzneimittel · 2026-09-30 · not reviewed by a clinician
Quelle: Swissmedic. The publisher’s terms do not grant reproduction, so text is shortened and linked. Publisher’s terms.